Facial masks cause coronavirus case plateau but say ‘not out of the woods’: HHS secretary


The cases are “stagnating” rather than springing up in coronavirus hot spots in states like California and Texas, likely because residents wear face masks and social distancing, Health and Human Services Secretary Alex Azar said Monday.

“While Dr. [Deborah] Birx says that we are seeing signs of stagnation, that we have not yet emerged from the forest, “Azar told” Fox & Friends. ” We believe it is due to the fact that people are actually wearing their masks … social distancing. “

DC MAYOR SAYS 27-STATE TRAVELERS MUST QUARANTINE ON ARRIVAL

“Governors have closed some of these bars where you just can’t stay socially distant, and you’re not going to put on a mask,” said Azar.

The next few months will be crucial because the United States has “really incredible therapeutic injections … as well as vaccines,” Azar said.

In this March 16, 2020 file photo, a subject receives an injection in the first-stage safety study clinical trial of a possible Moderna vaccine for COVID-19, the disease caused by the new coronavirus, in the Kaiser Permanente Washington Health Research Institute in Seattle.  (AP Photo / Ted S. Warren, file)

In this March 16, 2020 file photo, a subject receives an injection in the first-stage safety study clinical trial of a possible Moderna vaccine for COVID-19, the disease caused by the new coronavirus, in the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo / Ted S. Warren, file)

On Monday afternoon, the secretary and President Trump will visit Fujifilm Diosynth Biotechnologies, which makes components of a possible coronavirus vaccine, in Morrisville, North Carolina.

“The president and I are going to go to the Research Triangle in North Carolina today, where you will see one of the five vaccines we have invested in,” said Azar.

CLICK HERE TO GET THE FOX NEWS APP

Also on Monday, the Modern Massachusetts biotech company announced that it has begun its phase 3 trial of a coronavirus vaccine. Moderna is working with the NIH on the vaccine, and the effort is part of the Trump administration’s Operation Warp Speed.